Axsome Therapeutics to Participate in Upcoming Investor Conferences
NEW YORK, May 05, 2026 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it will participate in the following upcoming investor conferences in May: BofA Securities 2026 Health Care ConferenceFireside Chat: Tuesday, May 12, 2026, at […]
Original Source
Read the full article at Financialpost →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.